<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 81 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page80.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=81">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 81 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 81</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=81"><img src="../thumb/81.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>50 / 2020-04                                    Central Nervous System / Anaesthetics - 1.10 / 2 / 2.1 / 2.1.1 / 2.1.2
   toothache, hepatit., skin reacts., sweat., diaphores., ecchymos., musc.   div.pts.not show.an incr. respons./not toler.24 mg/day. Cont. maint.  (S5) TABS. 44/5.3/0944, 0945.
   cramps, urin.incont./freq., noctur., fatig., chest pain, accid., bone fract.  treatm. as long as therap.benef.exists. Consid.discont.if therapeut.  722728-001: 5 mg, 30, R357,32
   Warnings: Treatm.by exper.drs.only, maint. treatm. may be cont.  benef.no long.pres.  722729-001: 10 mg, 30, R369,23
   for as long as therapeut. benef. exper., reg.reassess., discont.when   Contraindications: Sev.imp.hepat.(CHILD score &gt;9)/ren.(creatin.   Dosage: Adults/elderly: Init.5 mg once dly.in even. prior to retir.
   therap. eff.no long.evid., use in other dement.type. /memory impairm.   clear.&lt;9 mlmin.)funct., urin. outflow obstruct., recent bladd.surg.  10 mg may be benefit.for some pts. Dos.may be incr.aft.4-6 wks. to
   not est., succinylcholine-type musc. relax.dur.anaesthes.poss.exag-  Side effects: Anaem., thrombocytopen., hypersens., decr.appet./  max.dly dos.of 10 mg once dly.depend.on clinic.respons.assessm.
   ger., sick-sinus syndr./other supraventric.card.conduct. condits. due to   weight., dehydrat., hyperglycaem., incr.alkaline phosph., vis./audit.   Contraindications: Piperidine derivat. hypersens., childr.& adolesc.
   poss.vagoton.effs.on heart rate, heart block/long sinus.paus., monit.  hallucinat., depress., insomn., anorex., somnol., agitat., confus., anx.,   und.18 yrs., safety in pregn. & lactat.not est.
   act./occult GI bleed., poss.bladd.outflow obstruct., neurolog. condits.   paranoid react., incr.libido, delir., suicid.ideat., suicide, headache,   Side effects: Syncop.episod., incr.gastr.secret., seiz., weight
   poss.cause gen.convuls., extrapyramid. sympt. induct./exacerb.po-  lethargy, trem., dizzin., syncope, paraesthes., dysgeus., hypersomn.,   loss, cold, flu., URTI, UTI, bld. dyscras., GI disturbs., dehydrat., hy-
   tent., asthma hist., obstruct. pulm.dis., avoid concom.acetylcholinest.   seizures, vertigo, hyperton., convuls., invol.musc.contracts., atax.,   ponatraem., psych./ card.disords., abnorm.cry., incr.libido, behav.
   inhib. & agonist/antagon.of cholinerg.syst., not recomm. aft.GI/bladd.  hyperkines., aprax., aphas., leg cramps, blurr.vis., tinnit., bradycard.,   chang., dizzin., headache, trem., CNS effs., aphas., atax., paraes-
   surg., no data for sev.hepat. impairm., safety in pregn.& lactat.not est.  supraventric.extrasystol., 1st degree AV block, sinus bradycard.,   thaes., extrapyramid.sympt., NMS, cataract, eye irrit., blurr.vis., ver-
   Special precautions: Withdr.ther.in case of unexpl. liv.dysfunct.,   palpitat., CF, myocard.ischaem./ infarct., atrial dysrhythm./fibrillat.,   tigo, ang., bradycard., AV/ sinoatr.block, vasodilat., hot flush., hypo-/
   monit.weight, not for lact. intol. pts., concom.rifampic./phenytoin/   supraventric. tachycard, QT prolong., bundle branch block, T-wave in-  hypertens., dyspn., sore throat, bronchit., toothache, GI haemorrh.,
   carbamazepine/ alcoh.        vers., ventric.tachycard., hyper-/hypotens., periph.oed., flush., postur.  pancreatit., hepatit., sweat., skin reacts. incl.diaphores./ecchymos.,
   Drug interactions: Reduc.lev.with enzym.induc., poss. interfer.with   hypotens., depend.oed., purpura, epistax., N&V, GI disturbs., retch.,   musc. cramps, arthrit., bone fract., urin.incont./ freq., noctur., bladd.
   anticholinerg.meds., synergist. eff.with succinylcholine/other neuro-  gastrit., melaena, dysphag., rectal haemorrh., dry mouth, incr.saliva,   outfl.obstruct., fatig., chest pain, accid.
   musc. block. agents/ cholinerg.agonists/ß-block.which aff.card. con-  diverticulit., gastroenterit., hiccup, oesophag.perforat., hepatit., elev.  Warnings and special precautions: Treatm.by exper. drs.only,
   duct., metab.inhibit.with CYP450/3A4 & 2D6 inhibits.  liv. enzym.,hyperhidros., Stev.Johns.syndr., ac. generalis. exanthemat.   maint.treatm.may be cont.for as long as therapeut.benef.exper., reg.
                                pustulos., erythema multif., musc. spasms/weakn., UTI, haematur.,   reassessm., discont. when therap.eff.no long.present, use in sev. Alz-
   MEMANTINE UNICHEM 10, (Activo) Unichem [P/S]  urin. incontin./retent., micturit.freq., cystit., noctur., ren. calculi, rhinit.,   heimer’s dement./other types of dement.or memory impairm.not est.,
   Memantine HCl                URTI, bronchit., cough., fatig., syncope, asthen., malaise, fall, back/  succinylcholine-type musc. relax.dur.anaesthes.poss.exagger., pts. re-
   Indications: Mod.sev.to sev.Alzheimer’s dis.  chest pain, fev., hepat.enzym.incr., not recomm.in GI obstruct./ re-  cover.from bladd./GI surg., sick-sinus syndr./ other supraventric.card.
   (S4) TABS, 46/5.11/0416      cov. from GI surg., concom.other cholinomimets., no studies on use   conduct.condits.due to poss.vagoton.effs.on heart rate, monit.for GI
   722058-001: 10 mg, 60, R254,41  in pregn./lactat., no data avail.on paed.use.  bleed. sympt.esp.with concom.NSAIDs/ulc.dis.hist., gen. convuls.,
   Dosage: Effic.beyond 6 mnths.not est. Exper. physic.supervis.necess.   Warnings and special precautions: Effic. beyond 6 mnths not   asthma/COPD or hist. thereof poss. aggravat., avoid concom.other
                 st
   Adults: Init.5 mg dly.in morn.dur.1  wk with upward titrat.of 5mg   est., benef.in other types of dement./memory impairm.not est., only   acetylcholinesterase inhibits./cholinerg.syst. agonists/ antagon.,
   2x/dly in 2  wk. 3  wk: 10 mg in morn.& 5 mg in aftern. From 4   th  init.if caregiv. avail.to reg.monit.meds.intake, inform pts. of signs of   monit.weight, GI disturbs. more freq.in females, porphyr., lact.intol.
       nd
           rd
   wk.cont.with recomm. maint.dos.of 20 mg/ day giv.as 10 mg 2xdly.   ser.skin reacts. & discont.at first appear. of skin rash., monit.weight,   Drug interactions: Poss.interfer.with anticholinerg. meds., syn-
   Max.dly dos: 20 mg/day.      sick sinus syndr., supraventric.card.conduct.disturbs., CV dis. incl   ergist.eff.with succinylcholine/ simil.neuroblock.agents/ cholinerg.
   Contraindications: Safety & effic in childr.& adolesc. und.18 yrs.  immed.post-MI period/new-onset atrial fibrillat./ 2nd degree heart   agon./β-blocks which eff.card.conduct., poss. incr.gastr.secret.with
   Side effects: Thrombocytopen., ac.pancreatit., hypoglycaem., GI   block or great./ unstab. ang.pector/ CHF, concom.meds.that signif.   NSAIDs, incr.elimin. rate with CYP2D6 & CYP3A4 induc.eg.phenytoin/
   disturbs., hyperlipidaem., psych. disords., CNS effs., dizzin., head-  reduc. heart rate, pts.with uncorrect.electrol.disturb., pts. at risk of de-  carbamazepine/alcoh./dexamethasone/ rifampicin/ phenobarb., me-
   ache, dyskines., somnol., abnorm. gait, grand mal convuls., NMS,   velop.pept.ulc. /ulc.hist./concom. NSAID’s, epilep.as convuls.thresh.  tab.poss.inhibit.by CYP3A4 eg. ketoconazole/itraconazole/ erythro-
   tard.dyskines., carpal tunnel syndr., restlessn., AV block, prolong.QT   poss.low., asthma, chron.obstruct.bronchit., not indic.in mild cognit.   mycin & CYP2D6 inhibits.eg.fluoxetine/ quinidine.
   interv., superventric. tachycard., hypertens., cerebr. infarct., IC haem-  impairm., reproduct.toxic.in animals, re-assess clinic.benef.reg., no
   orrh., claudicat., cough., dyspn., URTI, bronchit., aspirat. pneum., ileus,   rebound eff.aft.abrupt discont., mod.to sev.hepat./ren.impairm., en-
   colit., dysphag., gastro-oesophag. reflex, Stev.-John.syndr., hyper-  sure adeq. fluid intake dur.treatm., concom.meds.that have potent.
   ton., arthralg., back/ chest pain, bone fract., urin.incont., cystit., UTI,   to cause torsade’s de pointes  2  ANAESTHETICS
   hepat./ac.ren.fail., incr.libido, impot., inflict. inj., periph.oed., fatig.,   Interactions: Eff.of anticholinerg.meds.antagon., pharmacodynam.
   flu-like syndr., malaise.    interact.poss.with meds. signif. reduc. heart rate, succinylcholine-
   Warnings and special precautions: No data on hepat./sev.ren.  type musc. relaxat. dur.anaesthes.poss.exaggerat., potent. inhibit.of   BRIDION, MSD (Pty) Ltd
   impairm., convuls.risk, safety & effic. pregn.& lactat.not est., limit.data   CYP2D6/CYP3A4 poss.incr.cholinerg.S/E dur.treatm.init.  See Section 29
   on recent MI/CHF/uncontr. hypertens.& these pts.to be monit. reg.,
   avoid concom.amantadine/ketamine or dextromethorph., elderly&gt;   REMINYL CR, Janssen Pharmaceutica [P/S]  2.1   General anaesthetics
   65 yrs., alkaline condits reduc.eliminat. rate theref.monit.if urine pH   Galantamine hydrobromide equiv.to galantamine
   rais., poss. dantrolene/baclofen dos.adjustm.  Indications: Mild to mod.sev.dement.of Alzheimer type
   Drug interactions: L-dopa/dopaminerg.agon.& anticholinerg.effs.  (S4) CR CAPS, 38/5.3/0311, 0312, 0313
   enhanc., barbits.& neurolept. effs.reduc., effs.of dantrolene/baclofen   714432-001: 8 mg, 28, R1 071,56  2.1.1   Inhalation anaesthetics
   poss. alter., cimetid./ ranitid./procainam. /quinidine/ quinine & nico-  714433-001: 16 mg, 28, R1 071,56
   tine plasma lev.potent. incr., decr. hydrochlorothiaz.AUC & C max., more   714434-001: 24 mg, 28, R1 500,29  SOJOURN, Safeline [P/S]
   freq./sev.S/E with some other NMDA antagon.  Dosage: Admin.once dly.in morn.pref.with food. Start.dos: 8 mg/  Sevoflurane
                                day x4 wks. Init.maint. dos: 16 mg/day x at least 4 wks. May be incr.
   MEMOR, (Cipla Medpro) Zydus [P/S]  to maint.dos of 24 mg/day.aft.appropr. assessm. incl.eval.of clinic.  Indications: Induct. & maint.of gen.anaesthes.in adult & paed.pts.
                                                              for in/outpatient surg.
   Memantine HCl                benef.& toler. Dos. reduct.to 16 mg/day may be cons.in indiv. pts.   (S5) LIQ, 41/2.1/0098
   Indications: Mod.sev.to sev.Alzheimer’s dis.  not show.an incr.respons./not toler.24 mg/day. Cont. maint.treatm.  709325-001: 250 ml, R1 593,38
   (S4) TABS, 44/34/1014        as long as therap.benef.exists.  For furth.details see prof.info.
   721208-001: 10 mg, 60, R294,07  Contraindications: Safety in sev.liv./ren. impairm. not est., urin.
   Dosage: Effic.beyond 6 mnths.not est. Exper. physic.supervis.necess.  outflow obstruct., recent bladd. surg., galactose intol., Lapp lactase
   Adults: Init.5 mg dly.in morn.dur.1  wk with upward titrat.of 5mg   defic., gluc.-galactose malabsorpt., not recomm.in GI obstruct./ re-  2.1.2   Parenteral anaesthetics
                 st
           rd
   2x/dly in 2  wk. 3  wk: 10 mg in morn.& 5 mg in aftern. From 4   th  cov.from GI surg., concom.other cholinomimets., no studies on use
       nd
   wk.cont.with recomm.maint.dos.of 20 mg/ day giv. as 10 mg 2xdly.   in pregn./ lactat., no data avail.on paed.use, sev.imp. hepat. (CHILD
   Max.dly dos: 20 mg/day.      score &gt;9)/ren.(creatin.clear. &lt;9 mlmin.) funct.  B BRAUN ETOMIDATE, B Braun [P/S]
   Contraindications: Safety & effic in childr.& adolesc. und.18 yrs./  Side effects: Syncope, bradycard.somet. sev., fatig., asthen., ma-  Etomidate.
   pregn.& lactat.not est., no data on hepat./sev.ren.impairm.  laise, fall, injury, back/ chest pain, fev., dizzin., headache, trem., leth-  Indications: Complete anaesthes.induct. As no analgesic eff.pres.
   Side effects: Thrombocytopen., ac.pancreatit., GI disturbs., hy-  argy, dysgeus., hypersomn., paraesthes., vertigo, hyperton., con-  not suitable for mono-anaesthet.
   perlipidaem., dyskines., hypoglycaem., psych.effs., somnol., dizzin.,   vuls., invol.musc.contract., atax., hypo-/hyperkines., aprax., aphas.,   (S5) EMULS.FOR INJ. 41/2.2/0294 2 mg/ml.
   headache, abnorm. gait, convuls., NMS, tard.dyskines., carpal tunnel   leg cramps, tinnit., TIA, CVA, GI disturbs., melaena, dysphag., rect.  717646-001: 10x10 ml, R1 442,12
   syndr., restlessn., AV block, prolong.QT interv., superventric. tachy-  haemorrh., diverticulit., oesophag.perforat., AV block, palpitat., sinus   For furth.details refer to manufact. prod. lit.
   card., hypertens., thromboembol., cerebr.infarct., IC haemorrh., cough.,   bradycard., supraventr. extrasystol./ tachycard, CF, MI, myocard. is-  B BRAUN PROPOFOL 1%, B Braun Medical [P/S]
   bronchit., dyspn., URTI, aspirat.pneum., ileus, colit., dysphag., gastro-  chaem., atrial dysrhythm./fibrillat., QT prolong., bundle branch block,   Propofol
   oesophag.refl., hepat./ ac. ren.fail., Stev.-John.syndr., hyperton., ar-  T-wave invers., ventr. tachycard., dehydrat., hyperglycaem., decr.ap-  Indications: Induct.& maint.of gen.anaesth.in pts.over 3 yrs., sedat.
   thralg., back/chest pain, bone fract., claudicat., urin.incont., cystit.,   pet./ weight, musc.spasm/-weakn., psych. disords.incl. depress.  of ventilat.adult pts.receiv. intens.care for up to 72 hrs.
   UTI, incr.libido, impot., periph. oed., fatig., flu-like syndr., malaise.  with suicidal./hallucinat./paronir., incr. libido, rhinit., URTI, bronchit.,   (S5) 1% INJ, 39/2.1/0077. 10 mg/ml
   Special precautions: Epilep., convuls.risk, poss. dantrolene/ba-  cough., hyperhidros., UTI, haematur., urin.incont./retent., micturit.  710434-002: 5x20 ml amps, R147,35
   clofen dos.adjustm., avoid concom. amantadine/ketamine or dex-  freq., cystit., noctur., ren.calculi, anaem., periph.oed., hyper-/hypo-  For further details see manufacturers lit.
   tromethorph., ren. funct. impairm., alkaline condits reduc.eliminat.   tens., flush., postur.hypotens., depend. oed., purpura, epistax., throm-
   rate theref.monit.if urine pH rais., limit.data on recent MI/CHF/un-  bocytopen., hypersens., dehydrat.somet. sev., elev.liv.enzym., hepatit.,   DIPRIVAN 1% & 2%, (Aspen Pharmacare) Pharmacare [P/S]
   contr.hypertens.& these pts.to be monit.reg.  hypokalaem., lethargy, blurr.vis., dysgeus., CNS effs.  Propofol.
   Drug interactions: L-dopa/dopaminerg.agon.& anticholinerg.effs.  Special precautions: Effic.beyond 6 mnths not est., benef.in other   Indications: Induct.& maint.of gen.anaesth., sedat. of ventilat.
   enhanc., barbits.& neurolept. effs.reduc., effs.of dantrolene/baclofen   types of dement./memory impairm.not est., monit.weight, sick sinus   adult pts.receiv.intens.care for up to 72 hrs., conscious sedat.for
   poss. modif., more freq./sev.S/E with some other NMDA antagon.,   syndr., supraventric.card. conduct.disturbs., concom. meds. that sig-  surg.& diagnost. proced. in adults prov.adeq.facilit.exist.& admin.
   cimetid./ranitid./procainam. /quinidine/ quinine & nicotine plasma   nific.reduc.heart rate, pts.at risk of develop.pept.ulc./ulc.hist./concom.  by qualif. anaesthet.
   lev.poss.incr., decr. hydrochlorothiaz.AUC & C max.  NSAID’s, epilep.as convuls.thresh.poss.low., asthma, chron. obstruct.   (S5) 1% INJ, [P/S] T/2.1/226. 10 mg/ml
   REMCEPT XL, Actavis [P/S]    bronchit., not indicat.in mild cognit. impairm., re-assess clinic.benef.  720461-006: 5x20 ml amps., R308,52
                                                              (S5) 1% IV INFUS, [P/S] X/2.1/30, 31. 10 mg/ml
                                reg., no rebound eff.aft.abrupt discont., mod.to sev.hepat./ren. im-
   Galantamine hydrobromide equiv.to galantamine  pairm., ensure adeq.fluid intake dur.treatm.  785547-002: 1x50 ml vial, R157,58
   Indications: Mild to mod.sev.dement.of Alzheimer type  Drug interactions: Eff.of anticholinerg.meds. antagon., pharma-  797782-001: 1x100 ml vial, R308,52
   (S4) XL CAPS, 46/5.3/0998, 0999, 1000  codynam.interact.poss.with meds. signific.reduc.heart rate, suc-  (S5) 2% IV INFUS, [P/S] 36/2.1/0084. 20 mg/ml
   723726-001: 8 mg, 30, R659,54  cinylcholine-type musc.relaxat.dur. anaesthes. poss. exaggerat.,   Indications: Induct.& maint.of gen.anaesth., sedat. of ventilat.adult
   723727-001: 16 mg, 30, R659,54  potent.inhibit.for CYP2D6/CYP3A4 poss.incr.AUC./cholinerg.S/E   pts.receiv.int.care for up to 72 hrs.
   723728-001: 24 mg, 30, R916,03  incid.dur.treatm.init.     701562-003: 1x50 ml vial, R315,13
   Dosage: Adults: Admin.once dly.in morn.pref. with food. Start.dos:   For further details see professional info
   8 mg/day x4 wks. Init.maint. dos: 16 mg/day x at least 4 wks. May   ZEPANALZ, Aurobindo [P/S]
   be incr.to maint. dos of 24 mg/day.aft.appropr.assessm. incl. eval.  Donepezil HCl  FENTANYL FRESENIUS AMPS, Fresenius Kabi [N/P/S in C]
   of clinic.benef.& toler. Dos.reduct.to 16 mg/ day may be cons.in in-  Indications: Symtomat.treatm.of mild to mod. dement. of Alzheimer’s dis.  Fentanyl citrate.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page80.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page76.html">76</a>&nbsp;&nbsp;&nbsp;<a href="page77.html">77</a>&nbsp;&nbsp;&nbsp;<a href="page78.html">78</a>&nbsp;&nbsp;&nbsp;<a href="page79.html">79</a>&nbsp;&nbsp;&nbsp;<a href="page80.html">80</a>&nbsp;&nbsp;&nbsp;<a href="page81.html">81</a>&nbsp;&nbsp;&nbsp;<a href="page82.html">82</a>&nbsp;&nbsp;&nbsp;<a href="page83.html">83</a>&nbsp;&nbsp;&nbsp;<a href="page84.html">84</a>&nbsp;&nbsp;&nbsp;<a href="page85.html">85</a>&nbsp;&nbsp;&nbsp;<a href="page86.html">86</a>
             </td>
             <td width="35%"><a href="page82.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page82.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
